With the BD BBL™ Sensi-Disc™ portfolio, BD offers to laboratories an accurate, convenient, and broad disc diffusion solution that provides information to clinicians to help guide their treatment decisions.
1. Ahman J, et al., The quality of antimicrobial discs from nine manufacturers- EUCAST evaluations in 2014 and 2017, Clinical Microbiology and Infection(2018), https://doi.org/10.1016/j.cmi.2018.05.021.
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.